Effector Therapeutics, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
10-Q: eFFECTOR Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
eFFECTOR Therapeutics reports its financial results for the first quarter of 2024, highlighting key financial metrics and providing updates on its clinical development programs.